Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2012 (2012), Article ID 164082, 4 pages
http://dx.doi.org/10.1155/2012/164082
Case Report

Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome

1Pediatric Hematology and Oncology Department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran 15468-15514, Iran
2Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD 21218, USA

Received 22 August 2012; Accepted 15 October 2012

Academic Editors: S. Aksoy, K. Aogi, and F. A. Mauri

Copyright © 2012 Samin Alavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Samin Alavi, Ali Kord Valeshabad, Borhan Moradveisi, Ali Aminasnafi, and Mohammad Taghi Arzanian, “Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome,” Case Reports in Oncological Medicine, vol. 2012, Article ID 164082, 4 pages, 2012. doi:10.1155/2012/164082